Results 121 to 130 of about 14,794 (139)

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

Cancer, 2001
Anthony Howell, James R Berenson, L Porter   +2 more
exaly  

A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma

Cancer, 2008
Mario Boccadoro, Enrico Balleari, Pellegrino Musto   +2 more
exaly  

Zoledronic-acid

Reactions Weekly, 2019
openaire   +1 more source

Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study

Annals of Oncology, 2012
Massimo di Maio, Michelino de Laurentiis, Alessandro Morabito   +2 more
exaly  

The efficacy of zoledronic acid in breast cancer adjuvant therapy: A meta-analysis of randomised controlled trials

European Journal of Cancer, 2012
Wenjin Yin, Liheng Zhou, Tingting Yan
exaly  

STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells

Biomedicine and Pharmacotherapy, 2013
Cigir Biray Avci, Guray Saydam, Fahri Şahin   +2 more
exaly  

Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis

Clinical Therapeutics, 2010

exaly  

Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancer

Annals of Oncology, 2012
Antonella de Luca, Nicola Normanno
exaly  

Zoledronic acid infusion for lumbar interbody fusion in osteoporosis

Journal of Surgical Research, 2014
Kuo-Feng Huang
exaly  

Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation

Kidney International, 2003
exaly